- Home
- HYMC vs ZYXI Comparison
HYMC vs ZYXI Comparison
Compare HYMC & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYMC
- ZYXI
- Stock Information
- Founded
- HYMC N/A
- ZYXI 1996
- Country
- HYMC United States
- ZYXI United States
- Employees
- HYMC N/A
- ZYXI N/A
- Industry
- HYMC Precious Metals
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HYMC Basic Materials
- ZYXI Health Care
- Exchange
- HYMC Nasdaq
- ZYXI Nasdaq
- Market Cap
- HYMC 75.4M
- ZYXI 66.5M
- IPO Year
- HYMC N/A
- ZYXI N/A
- Fundamental
- Price
- HYMC $3.49
- ZYXI $2.02
- Analyst Decision
- HYMC
- ZYXI Buy
- Analyst Count
- HYMC 0
- ZYXI 3
- Target Price
- HYMC N/A
- ZYXI $6.00
- AVG Volume (30 Days)
- HYMC 267.0K
- ZYXI 176.4K
- Earning Date
- HYMC 05-13-2025
- ZYXI 07-24-2025
- Dividend Yield
- HYMC N/A
- ZYXI N/A
- EPS Growth
- HYMC N/A
- ZYXI N/A
- EPS
- HYMC N/A
- ZYXI N/A
- Revenue
- HYMC N/A
- ZYXI $172,401,000.00
- Revenue This Year
- HYMC N/A
- ZYXI N/A
- Revenue Next Year
- HYMC N/A
- ZYXI $19.55
- P/E Ratio
- HYMC N/A
- ZYXI N/A
- Revenue Growth
- HYMC N/A
- ZYXI N/A
- 52 Week Low
- HYMC $1.95
- ZYXI $1.66
- 52 Week High
- HYMC $3.95
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- HYMC 61.78
- ZYXI 40.53
- Support Level
- HYMC $2.71
- ZYXI $2.21
- Resistance Level
- HYMC $3.11
- ZYXI $2.66
- Average True Range (ATR)
- HYMC 0.22
- ZYXI 0.20
- MACD
- HYMC 0.03
- ZYXI 0.02
- Stochastic Oscillator
- HYMC 91.76
- ZYXI 5.19
About HYMC Hycroft Mining Holding Corporation
Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.